ConquerX's Incubator/Accelerator - II Round

ConquerX raised a round of funding on December 13, 2016. Investors include MassChallenge.

ConquerX is a company whose Ebegen technology represents an approach to cancer diagnostics and screening by leveraging a new class of biomarkers - microRNAs - to earlier detect up to eighteen types of…

Articles about ConquerX's Incubator/Accelerator - II Round: